Chart BKHA with indicators, scan for setups and get alerts
This page is open to everyone. A free ScanPro account adds the interactive parts, along with watchlists, paper trading with simulated money and the Academy's quizzes.
A full BKHA chart with indicator overlays, pattern markers and daily, weekly or intraday bars.
Scans of a whole index or list with 72 named conditions, 26 chart setups or a formula of your own.
Alerts and notifications when one fires on a stock you watch, on delayed market data.
Daily range (ATR)24.7%average true range, % of price
52w low $5.4752w high $23.00
Where price sits today against its own history. A description, not a forecast.
Valuation
P/E (trailing)—
P/E (forward)—
PEG—
Price / sales—
Price / book−6.04
EV / EBITDA—
P/E since Jun 160.3 – 67.1
Company figures as of Oct 15, 2026.
Seasonality
+1.4
J
-0.0
F
+0.9
M
+0.6
A
+0.9
M
+0.3
J
+0.9
J
+0.6
A
+1.6
S
+1.7
O
-0.7
N
+0.3
D
Average return in each calendar month, Jun 30, 2024 to Sep 30, 2026. 3 years is 3 observations a month: too few to call a pattern, so read it as history, not a calendar to trade.
Financials
As reported in the company's SEC filings. Latest: Q3 FY2026, ended Aug 31, 2026.
Free shows the latest quarter, the latest year and the last 12 months. Plus shows every period and the growth figures.See Plus
Figures are as each 10-Q and 10-K reported them, in the company's own fiscal calendar, not restated later. A company that changes how it reports a line can make one period look out of step with the rest. Growth compares the same period a year earlier and is left blank when the year before was a loss. Banks and insurers report no gross profit, so rows they don't file are left out. Every filing on SEC EDGAR
Black Hawk Acquisition Corporation, a special purpose acquisition company, has entered into a business combination agreement with Vesicor Therapeutics. This transaction is expected to help Vesicor become a public company and access the capital needed to advance its drug candidate.
Securing an accomplished CEO for its de-SPAC acquisition target strengthens the merger prospects and demonstrates progress toward completing the transaction. The appointment of a well-credentialed leader enhances confidence in the combined entity's ability to execute on development and commercialization plans.
Tone is the news provider's automated reading of each article for this stock. It describes the article, not what the price will do.
Figures describe the past, not what the price will do next. Educational tools, not investment advice.